Viking Therapeutics, Inc.
VKTX
Revenue
0.00
0.000.00%
3 Months ChangeAssets
908.32M
▼-29.57M▼-3.15%
3 Months ChangeLiabilities
28.04M
▲1.60M▲6.06%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-23
Form 10-Q
ID: 0000950170-24-116708
2024-10-23
Form 8-K
ID: 0000950170-24-116642
2024-07-24
Form 10-Q
ID: 0000950170-24-086111
2024-07-24
Form 8-K
ID: 0000950170-24-086039
2024-06-04
Form 8-K
ID: 0000950170-24-068297
2024-05-23
Form 8-K
ID: 0000950170-24-063707
2024-04-25
Form 10-Q
ID: 0000950170-24-047833
2024-04-24
Form 8-K
ID: 0000950170-24-047567
2024-03-26
Form 8-K
ID: 0000950170-24-036151
2024-03-04
Form 8-K
ID: 0000950170-24-024878